BLEX 404 Oral Liquid
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BLEX 404 Oral Liquid, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BLEX 404 Oral Liquid in Patients With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-Risk Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML) [Phase 2]